Explore This Research Award in CaptureIQ
Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.
Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- ACTIVE MOTIF, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- N7GVF5GCF3A6
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
DESCRIPTION (Applicant's abstract): In this application we will discuss the
rationale for the development of a novel method for chemically tagging a
synthetic oligonucleotide to the 5'-end of full-length mRNAs using the cap
structure (7-methyl guanosine triphosphate, m7Gppp). There are two major
technical limitations in full-length cDNA library construction. The first is
reduced efficiency of the reverse transcriptase reaction and the second
limitation is the inability to efficiently select only full-length cDNA. This
is compounded by the need to use RNase H to generate RNA primers for second
strand synthesis, which biases against the isolation full-length cDNAs. Current
RACE methods (Rapid Amplification of cDNA ends) and commercial kits to isolate
full-length cDNAs are technically dificule whith variable at best. In this
proposal we have designed a procedure which will address some of the problems
inherent with current protocols. The technique can be used as either a 5'-RACE
method or a full-length cDNA library construction method. By attaching a
ribo-oligonucleotide through the morpholino-nucleoside residue to the 5'-capped
end of mRNA, the reverse transcriptase can read through the cap structure, and
using the attached ribo-oligonucleotide as a template, continuing systhesis of
first strand cDNA to the end of this oligo. The complementary sequence to the
ribooligonucleotide becomes attached to the 3'-end of the cDNA, presenting a
known priming site for second strand synthesis to generate full-length double
strand cDNA, This method is especially advantageous in that it does not require
an RNase H step to generate primers for second strand synthesis, which in
itself biases against 5'-end identification.
PROPOSED COMMERCIAL APPLICATION:
The ultimate goal will be to generate an efficient method for specifically tagging the 5'-cap
structure of full-length cDNA. This technology will hopefully supercede the current
technologies, which are technically difficult and inefficient. Quality full-length cDNA
libraries and 5'-EST libraries will be developed. These libraries will result in the
identification of novel 5' -untranslated regions and longer and rarer genes.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
Research funding history
23 SBIR/STTR records share this UEI (2001–2025). Reported award amounts total $5,925,376. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation
Agency intelligence
Department of Health and Human Services
Back to SBIR/STTR Research Awards